Skip to content
1887

Microbial Genomics logo Microbial Genomics

Volume 11, Issue 2

Whole-genome sequencing of clinical isolates from a tertiary hospital in Terengganu, Malaysia (2011–2020), revealed the predominance of the Global Clone 2 lineage Open Access

Abstract

Carbapenem-resistant is recognized by the World Health Organization (WHO) as one of the top priority pathogens. Despite its public health importance, genomic data of clinical isolates from Malaysia remain scarce. In this study, whole-genome sequencing was performed on 126 . isolates collected from the main tertiary hospital in the state of Terengganu, Malaysia, over a 10-year period (2011–2020). Antimicrobial susceptibilities determined for 20 antibiotics belonging to 8 classes showed that 77.0% (=97/126) of the isolates were categorized as multidrug resistant (MDR), with all MDR isolates being carbapenem resistant. Multilocus sequence typing analysis categorized the Terengganu clinical isolates into 34 Pasteur and 44 Oxford sequence types (STs), with ST2 of the Global Clone 2 lineage identified as the dominant ST (=76/126; 60.3%). The ST2 isolates could be subdivided into six Oxford STs with the majority being ST195 (=35) and ST208 (=17). Various antimicrobial resistance genes were identified with the -encoded carbapenemase being the predominant acquired carbapenemase gene (=90/126; 71.4%). Plasmid-encoded genes were identified in nearly all (=122/126; 96.8%) of the isolates with the majority being Rep_3 family (=121). Various virulence factors were identified, highlighting the pathogenic nature of this bacterium. Only 14/126 (11.1%) of the isolates were positive for the carriage of CRISPR-Cas arrays with none of the prevalent ST2 isolates harbouring them. This study provided a genomic snapshot of the isolates obtained from a single tertiary healthcare centre in Malaysia over a 10-year period and showed the predominance of a single closely related ST2 lineage, indicating the entrenchment of this clone in the hospital.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): Acinetobacter baumannii , GC2 lineage , genome sequencing , Malaysia and multidrug resistant
Funding
This study was supported by the:
  • Kementerian Pendidikan Malaysia (Award FRGS/1/2018/SKK11/UNISZA/01/1)
    • Principal Award Recipient: SalwaniIsmail
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001345
2025-02-05
2026-01-20

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/mgen/11/2/mgen001345.html?itemId=/content/journal/mgen/10.1099/mgen.0.001345&mimeType=html&fmt=ahah

References

  1. Shamsizadeh Z, Nikaeen M, Nasr Esfahani B, Mirhoseini SH, Hatamzadeh M et al. Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections. Environ Health Prev Med 2017; 22:44 [View Article] [PubMed]
     [Google Scholar]
  2. Hu S, Niu L, Zhao F, Yan L, Nong J et al. Identification of Acinetobacter baumannii and its carbapenem-resistant gene blaOXA-23-like by multiple cross displacement amplification combined with lateral flow biosensor. Sci Rep 2019; 9:17888 [View Article] [PubMed]
     [Google Scholar]
  3. Heindorf M, Kadari M, Heider C, Skiebe E, Wilharm G. Impact of Acinetobacter baumannii superoxide dismutase on motility, virulence, oxidative stress resistance and susceptibility to antibiotics. PLoS One 2014; 9:e101033 [View Article] [PubMed]
     [Google Scholar]
  4. Teerawattanapong N, Panich P, Kulpokin D, Na Ranong S, Kongpakwattana K et al. A systematic review of the burden of multidrug-resistant healthcare-associated infections among intensive care unit patients in southeast Asia: the rise of multidrug-resistant Acinetobacter baumannii. Infect Control Hosp Epidemiol 2018; 39:525–533 [View Article] [PubMed]
     [Google Scholar]
  5. Mohd Sazlly Lim S, Zainal Abidin A, Liew SM, Roberts JA, Sime FB. The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: a systematic review and meta-analysis. J Infect 2019; 79:593–600 [View Article]
     [Google Scholar]
  6. World Health Organization (WHO) WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. n.d https://www.who.int/publications/i/item/9789240093461
  7. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 2018; 18:318–327 [View Article] [PubMed]
     [Google Scholar]
  8. Whiteway C, Breine A, Philippe C, Van der Henst C. Acinetobacter baumannii. Trends Microbiol 2022; 30:199–200 [View Article] [PubMed]
     [Google Scholar]
  9. Ministry of Health Malaysia National surveillance of antimicrobial resistance; 2022 https://imr.nih.gov.my/images/uploads/NSAR/2022/NSAR-REPORT_2022_to-be-published.pdf
  10. Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist 2018; 11:1249–1260 [View Article] [PubMed]
     [Google Scholar]
  11. Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens 2021; 10:373 [View Article] [PubMed]
     [Google Scholar]
  12. Bardbari AM, Arabestani MR, Karami M, Keramat F, Alikhani MY et al. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates. Microb Pathog 2017; 108:122–128 [View Article] [PubMed]
     [Google Scholar]
  13. Guo T, Yang J, Sun X, Wang Y, Yang L et al. Whole-genome analysis of Acinetobacter baumannii strain AB43 containing a type I-FB CRISPR-Cas system: insights into the relationship with drug resistance. Molecules 2022; 27:5665 [View Article] [PubMed]
     [Google Scholar]
  14. Mohd Rani F, A Rahman NI, Ismail S, Abdullah FH, Othman N et al. Prevalence and antimicrobial susceptibilities of Acinetobacter baumannii and non-baumannii Acinetobacters from Terengganu, Malaysia and their carriage of carbapenemase genes. J Med Microbiol 2018; 67:1538–1543 [View Article] [PubMed]
     [Google Scholar]
  15. CLSI Performance standards for antimicrobial susceptibility testing. In CLSI Supplement M100, 30th edn. Clinical and Laboratory Standards Institute; 2020
     [Google Scholar]
  16. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268–281 [View Article] [PubMed]
     [Google Scholar]
  17. Andrews S. FastQC: a quality control tool for high throughput sequence data; 2010 https://www.bioinformatics.babraham.ac.uk/projects/fastqc/
  18. Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 2017; 13:e1005595 [View Article] [PubMed]
     [Google Scholar]
  19. Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics 2013; 29:1072–1075 [View Article] [PubMed]
     [Google Scholar]
  20. Alattraqchi AG, Mohd Rani F, A. Rahman NI, Ismail S, Cleary DW et al. Complete genome sequencing of Acinetobacter baumannii AC1633 and Acinetobacter nosocomialis AC1530 unveils a large multidrug-resistant plasmid encoding the NDM-1 and OXA-58 carbapenemases. mSphere 2021; 6:e01076-20 [View Article]
     [Google Scholar]
  21. Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 2015; 31:3691–3693 [View Article] [PubMed]
     [Google Scholar]
  22. Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 2021; 49:W293–W296 [View Article] [PubMed]
     [Google Scholar]
  23. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 2010; 5:e10034 [View Article] [PubMed]
     [Google Scholar]
  24. Bartual SG, Seifert H, Hippler C, Luzon MAD, Wisplinghoff H et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005; 43:4382–4390 [View Article] [PubMed]
     [Google Scholar]
  25. Cahill SM, Hall RM, Kenyon JJ. An update to the database for Acinetobacter baumannii capsular polysaccharide locus typing extends the extensive and diverse repertoire of genes found at and outside the K locus. Microb Genom 2022; 8:mgen000878 [View Article] [PubMed]
     [Google Scholar]
  26. Liu B, Zheng D, Zhou S, Chen L, Yang J. VFDB 2022: a general classification scheme for bacterial virulence factors. Nucleic Acids Res 2022; 50:D912–D917 [View Article] [PubMed]
     [Google Scholar]
  27. Marazzato M, Scribano D, Sarshar M, Brunetti F, Fillo S et al. Genetic diversity of antimicrobial resistance and key virulence features in two extensively drug-resistant Acinetobacter baumannii isolates. Int J Environ Res Public Health 2022; 19:2870 [View Article] [PubMed]
     [Google Scholar]
  28. Lam MMC, Koong J, Holt KE, Hall RM, Hamidian M. Detection and typing of plasmids in Acinetobacter baumannii using rep genes encoding replication initiation proteins. Microbiol Spectr 2023; 11:e0247822 [View Article] [PubMed]
     [Google Scholar]
  29. Tyumentseva M, Mikhaylova Y, Prelovskaya A, Tyumentsev A, Petrova L et al. Genomic and phenotypic analysis of multidrug-resistant Acinetobacter baumannii clinical isolates carrying different types of CRISPR/Cas systems. Pathogens 2021; 10:205 [View Article] [PubMed]
     [Google Scholar]
  30. Long L, You L, Wang D, Wang M, Wang J et al. Highly prevalent MDR, frequently carrying virulence genes and antimicrobial resistance genes in Salmonella enterica serovar 4,[5],12:i:- isolates from Guizhou Province, China. PLoS One 2022; 17:e0266443 [View Article] [PubMed]
     [Google Scholar]
  31. Katiyar A, Sharma P, Dahiya S, Singh H, Kapil A et al. Genomic profiling of antimicrobial resistance genes in clinical isolates of Salmonella Typhi from patients infected with Typhoid fever in India. Sci Rep 2020; 10:8299 [View Article] [PubMed]
     [Google Scholar]
  32. Schwan CL, Lomonaco S, Bastos LM, Cook PW, Maher J et al. Genotypic and phenotypic characterization of antimicrobial resistance profiles in non-typhoidal Salmonella enterica strains isolated from Cambodian informal markets. Front Microbiol 2021; 12:711472 [View Article] [PubMed]
     [Google Scholar]
  33. Hansen F, Porsbo LJ, Frandsen TH, Kaygisiz ANS, Roer L et al. Characterisation of carbapenemase-producing Acinetobacter baumannii isolates from Danish patients 2014-2021: detection of a new international clone - IC11. Int J Antimicrob Agents 2023; 62:106866 [View Article] [PubMed]
     [Google Scholar]
  34. Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom 2019; 5:e000306 [View Article] [PubMed]
     [Google Scholar]
  35. Castillo-Ramírez S, Graña-Miraglia L. Inaccurate multilocus sequence typing of Acinetobacter baumannii. Emerg Infect Dis 2019; 25:186–187 [View Article] [PubMed]
     [Google Scholar]
  36. Gaiarsa S, Batisti Biffignandi G, Esposito EP, Castelli M, Jolley KA et al. Comparative analysis of the two Acinetobacter baumannii Multilocus Sequence Typing (MLST) Schemes. Front Microbiol 2019; 10: [View Article]
     [Google Scholar]
  37. Hua X, Zhang L, He J, Leptihn S, Yu Y. Population biology and epidemiological studies of Acinetobacter baumannii in the era of whole genome sequencing: is the Oxford scheme still appropriate?. Front Microbiol 2020; 11:775 [View Article]
     [Google Scholar]
  38. Lean SS, Yeo CC, Suhaili Z, Thong KL. Whole-genome analysis of an extensively drug-resistant clinical isolate of Acinetobacter baumannii AC12: insights into the mechanisms of resistance of an ST195 clone from Malaysia. Int J Antimicrob Agents 2015; 45:178–182 [View Article] [PubMed]
     [Google Scholar]
  39. Lean SS, Yeo CC, Suhaili Z, Thong KL. Comparative genomics of two ST 195 carbapenem-resistant Acinetobacter baumannii with different susceptibility to polymyxin revealed underlying resistance mechanism. Front Microbiol 2015; 6:1445 [View Article] [PubMed]
     [Google Scholar]
  40. Wareth G, Linde J, Nguyen NH, Nguyen TNM, Sprague LD et al. WGS-based analysis of carbapenem-resistant Acinetobacter baumannii in Vietnam and molecular characterization of antimicrobial determinants and MLST in Southeast Asia. Antibiotics 2021; 10:563 [View Article] [PubMed]
     [Google Scholar]
  41. Migliaccio A, Bray J, Intoccia M, Stabile M, Scala G et al. Phylogenomics of Acinetobacter species and analysis of antimicrobial resistance genes. Front Microbiol 2023; 14:1264030 [View Article] [PubMed]
     [Google Scholar]
  42. Evans BA, Amyes SGB. OXA β-lactamases. Clin Microbiol Rev 2014; 27:241–263 [View Article] [PubMed]
     [Google Scholar]
  43. Nigro SJ, Hall RM. Does the intrinsic oxaAb (blaOXA-51-like) gene of Acinetobacter baumannii confer resistance to carbapenems when activated by ISAba1?. J Antimicrob Chemother 2018; 73:3518–3520 [View Article] [PubMed]
     [Google Scholar]
  44. Lam MMC, Hamidian M. Examining the role of Acinetobacter baumannii plasmid types in disseminating antimicrobial resistance. npj Antimicrob Resist 2024; 2: [View Article]
     [Google Scholar]
  45. Wiradiputra MRD, Thirapanmethee K, Khuntayaporn P, Wanapaisan P, Chomnawang MT. Comparative genotypic characterization related to antibiotic resistance phenotypes of clinical carbapenem-resistant Acinetobacter baumannii MTC1106 (ST2) and MTC0619 (ST25). BMC Genom 2023; 24:689 [View Article] [PubMed]
     [Google Scholar]
  46. Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P et al. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 2010; 54:4168–4177 [View Article] [PubMed]
     [Google Scholar]
  47. Lean SS, Yeo CC. Small, enigmatic plasmids of the nosocomial pathogen, Acinetobacter baumannii: good, bad, who knows?. Front Microbiol 2017; 8:1547 [View Article] [PubMed]
     [Google Scholar]
  48. Holt KE, Hamidian M, Kenyon JJ, Wynn MT, Hawkey J et al. Genome sequence of Acinetobacter baumannii strain A1, an early example of antibiotic-resistant global clone 1. Genome Announc 2015; 3:e00032-15 [View Article] [PubMed]
     [Google Scholar]
  49. Nie D, Hu Y, Chen Z, Li M, Hou Z et al. Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection. J Biomed Sci 2020; 27:26 [View Article] [PubMed]
     [Google Scholar]
  50. Nocera FP, Attili A-R, De Martino L. Acinetobacter baumannii: its clinical significance in human and veterinary medicine. Pathogens 2021; 10:127 [View Article] [PubMed]
     [Google Scholar]
  51. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15:167–193 [View Article] [PubMed]
     [Google Scholar]
  52. Sung JY, Koo SH, Kim S, Kwon GC. Persistence of multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23 and bap for 5 Years. J Microbiol Biotechnol 2016; 26:1481–1489 [View Article] [PubMed]
     [Google Scholar]
  53. Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist 2018; 11:2277–2299 [View Article] [PubMed]
     [Google Scholar]
  54. Sheldon JR, Skaar EP. Acinetobacter baumannii can use multiple siderophores for iron acquisition, but only acinetobactin is required for virulence. PLoS Pathog 2020; 16:e1008995 [View Article]
     [Google Scholar]
  55. Giardina BJ, Shahzad S, Huang W, Wilks A. Heme uptake and utilization by hypervirulent Acinetobacter baumannii LAC-4 is dependent on a canonical heme oxygenase (abHemO). Arch Biochem Biophys 2019; 672:108066 [View Article] [PubMed]
     [Google Scholar]
  56. Uber AP, Viana GF, Lodi FG, Dos Anjos Szczerepa MM, Carrara-Marroni FE et al. Adherence ability and serum resistance of different hospital clusters of Acinetobacter baumannii. Lett Appl Microbiol 2021; 73:132–138 [View Article] [PubMed]
     [Google Scholar]
  57. Lopez J, Ly PM, Feldman MF. The tip of the VgrG spike is essential to functional type VI secretion system assembly in Acinetobacter baumannii. mBio 2020; 11:e02761-19 [View Article] [PubMed]
     [Google Scholar]
  58. Bai B, Eales BM, Huang W, Ledesma KR, Merlau PR et al. Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by Acinetobacter baumannii. Virulence 2022; 13:1920–1927 [View Article] [PubMed]
     [Google Scholar]
  59. Shadan A, Pathak A, Ma Y, Pathania R, Singh RP. Deciphering the virulence factors, regulation, and immune response to Acinetobacter baumannii infection. Front Cell Infect Microbiol 2023; 13:1053968 [View Article] [PubMed]
     [Google Scholar]
  60. Carruthers MD, Nicholson PA, Tracy EN, Munson RS. Acinetobacter baumannii utilizes a type VI secretion system for bacterial competition. PLoS One 2013; 8:e59388 [View Article]
     [Google Scholar]
  61. Fitzsimons TC, Lewis JM, Wright A, Kleifeld O, Schittenhelm RB et al. Identification of novel Acinetobacter baumannii type VI secretion system antibacterial effector and immunity pairs. Infect Immun 2018; 86:e00297-18 [View Article]
     [Google Scholar]
  62. Zoued A, Brunet YR, Durand E, Aschtgen M-S, Logger L et al. Architecture and assembly of the Type VI secretion system. Biochim Biophys Acta 2014; 1843:1664–1673 [View Article] [PubMed]
     [Google Scholar]
  63. Lewis JM, Deveson Lucas D, Harper M, Boyce JD. Systematic identification and analysis of Acinetobacter baumannii type VI secretion system effector and immunity components. Front Microbiol 2019; 10:2440 [View Article] [PubMed]
     [Google Scholar]
  64. Repizo GD, Espariz M, Seravalle JL, Salcedo SP. Bioinformatic analysis of the type VI secretion system and its potential toxins in the Acinetobacter Genus. Front Microbiol 2019; 10:2519 [View Article] [PubMed]
     [Google Scholar]
  65. Le NH, Pinedo V, Lopez J, Cava F, Feldman MF. Killing of Gram-negative and Gram-positive bacteria by a bifunctional cell wall-targeting T6SS effector. Proc Natl Acad Sci U S A 2021; 118:e2106555118 [View Article] [PubMed]
     [Google Scholar]
  66. Weber BS, Hennon SW, Wright MS, Scott NE, de Berardinis V et al. Genetic dissection of the type VI secretion system in Acinetobacter and identification of a novel peptidoglycan hydrolase, TagX, required for its biogenesis. mBio 2016; 7:e01253-16 [View Article] [PubMed]
     [Google Scholar]
  67. Roshini J, Patro LPP, Sundaresan S, Rathinavelan T. Structural diversity among Acinetobacter baumannii K-antigens and its implication in the in silico serotyping. Front Microbiol 2023; 14:1191542 [View Article]
     [Google Scholar]
  68. Sorbello BM, Cahill SM, Kenyon JJ. Identification of further variation at the lipooligosaccharide outer core locus in Acinetobacter baumannii genomes and extension of the OCL reference sequence database for Kaptive. Microbial Genom 2023; 9:001042 [View Article]
     [Google Scholar]
  69. Wyres KL, Cahill SM, Holt KE, Hall RM, Kenyon JJ. Identification of Acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive. Microb Genom 2020; 6:e000339 [View Article] [PubMed]
     [Google Scholar]
  70. Ramirez MS, Penwell WF, Traglia GM, Zimbler DL, Gaddy JA et al. Identification of potential virulence factors in the model strain Acinetobacter baumannii A118. Front Microbiol 2019; 10:1599 [View Article]
     [Google Scholar]
  71. Wang Y, Yang J, Sun X, Li M, Zhang P et al. CRISPR-Cas in Acinetobacter baumannii contributes to antibiotic susceptibility by targeting endogenous AbaI. Microbiol Spectr 2022; 10:e0082922 [View Article] [PubMed]
     [Google Scholar]
  72. Makarova KS, Koonin EV. Annotation and classification of CRISPR-Cas systems. Methods Mol Biol 2015; 1311:47–75 [View Article] [PubMed]
     [Google Scholar]
  73. Makarova KS, Wolf YI, Iranzo J, Shmakov SA, Alkhnbashi OS et al. Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nat Rev Microbiol 2020; 18:67–83 [View Article] [PubMed]
     [Google Scholar]
  74. Fagerlund RD, Wilkinson ME, Klykov O, Barendregt A, Pearce FG et al. Spacer capture and integration by a type I-F Cas1-Cas2-3 CRISPR adaptation complex. Proc Natl Acad Sci U S A 2017; 114:E5122–E5128 [View Article] [PubMed]
     [Google Scholar]
  75. Guo T, Sun X, Li M, Wang Y, Jiao H et al. The involvement of the csy1 gene in the antimicrobial resistance of Acinetobacter baumannii. Front Med 2022; 9:797104 [View Article]
     [Google Scholar]
  76. Yadav G, Singh R. In silico analysis reveals the co-existence of CRISPR-Cas type I-F1 and type I-F2 systems and its association with restricted phage invasion in Acinetobacter baumannii. Front Microbiol 2022; 13:909886 [View Article] [PubMed]
     [Google Scholar]
  77. Karah N, Wai SN, Uhlin BE. CRISPR-based subtyping to track the evolutionary history of a global clone of Acinetobacter baumannii. Infect Genet Evol 2021; 90:104774 [View Article] [PubMed]
     [Google Scholar]
  78. Álvarez VE, Quiroga MP, Galán AV, Vilacoba E, Quiroga C et al. Crucial role of the accessory genome in the evolutionary trajectory of Acinetobacter baumannii global clone 1. Front Microbiol 2020; 11:342 [View Article] [PubMed]
     [Google Scholar]
  79. Abouelfetouh A, Torky AS, Aboulmagd E. Role of plasmid carrying blaNDM in mediating antibiotic resistance among Acinetobacter baumannii clinical isolates from Egypt. 3 Biotech 2020; 10:170 [View Article]
     [Google Scholar]
  80. Djordjevic SP, Jarocki VM, Seemann T, Cummins ML, Watt AE et al. Genomic surveillance for antimicrobial resistance - a One Health perspective. Nat Rev Genet 2024; 25:142–157 [View Article] [PubMed]
     [Google Scholar]
  81. Mohd Rani F, A Rahman NI, Ismail S, Alattraqchi AG, Cleary DW et al. Acinetobacter spp. infections in Malaysia: a review of antimicrobial resistance trends, mechanisms and epidemiology. Front Microbiol 2017; 8:2479 [View Article] [PubMed]
     [Google Scholar]
  82. Lean S-S, Suhaili Z, Ismail S, Rahman NIA, Othman N et al. Prevalence and genetic characterization of carbapenem- and polymyxin-resistant Acinetobacter baumannii Isolated from a Tertiary Hospital in Terengganu, Malaysia. ISRN Microbiol 2014; 2014:953417 [View Article] [PubMed]
     [Google Scholar]
  83. Ngoi ST, Chong CW, Ponnampalavanar SSLS, Tang SN, Idris N et al. Genetic mechanisms and correlated risk factors of antimicrobial-resistant ESKAPEE pathogens isolated in a tertiary hospital in Malaysia. Antimicrob Resist Infect Control 2021; 10:70 [View Article] [PubMed]
     [Google Scholar]
  84. Muzahid NH, Hussain MH, Huët MAL, Dwiyanto J, Su TT et al. Molecular characterization and comparative genomic analysis of Acinetobacter baumannii isolated from the community and the hospital: an epidemiological study in Segamat, Malaysia. Microb Genom 2023; 9:mgen000977 [View Article] [PubMed]
     [Google Scholar]
  85. Rao M, Rashid FA, Shukor S, Hashim R, Ahmad N. Detection of antimicrobial resistance genes associated with carbapenem resistance from the whole-genome sequence of Acinetobacter baumannii isolates from Malaysia. Can J Infect Dis Med Microbiol 2020; 2020:5021064 [View Article] [PubMed]
     [Google Scholar]
  86. Chukamnerd A, Singkhamanan K, Chongsuvivatwong V, Palittapongarnpim P, Doi Y et al. Whole-genome analysis of carbapenem-resistant Acinetobacter baumannii from clinical isolates in Southern Thailand. Comput Struct Biotechnol J 2022; 20:545–558 [View Article] [PubMed]
     [Google Scholar]
  87. Khuntayaporn P, Kanathum P, Houngsaitong J, Montakantikul P, Thirapanmethee K et al. Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study. Ann Clin Microbiol Antimicrob 2021; 20:19 [View Article] [PubMed]
     [Google Scholar]
  88. Loraine J, Heinz E, Soontarach R, Blackwell GA, Stabler RA et al. Genomic and phenotypic analyses of Acinetobacter baumannii isolates from three Tertiary Care Hospitals in Thailand. Front Microbiol 2020; 11:548 [View Article] [PubMed]
     [Google Scholar]
  89. Tada T, Uchida H, Hishinuma T, Watanabe S, Tohya M et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates from hospitals in Myanmar. J Glob Antimicrob Resist 2020; 22:122–125 [View Article] [PubMed]
     [Google Scholar]
  90. Xu A, Li M, Hang Y, Zeng L, Zhang X et al. Multicenter retrospective genomic characterization of carbapenemase-producing Acinetobacter baumannii isolates from Jiangxi patients 2021-2022: identification of a novel international clone, IC11. mSphere 2024; 9:e0027624 [View Article] [PubMed]
     [Google Scholar]
  91. Liu H, Moran RA, Doughty EL, Hua X, Snaith AE et al. Longitudinal genomics reveals carbapenem-resistant Acinetobacter baumannii population changes with emergence of highly resistant ST164 clone. Nat Commun 2024; 15:9483 [View Article]
     [Google Scholar]
  92. Adjei AY, Vasaikar SD, Apalata T, Okuthe EG, Songca SP. Phylogenetic analysis of carbapenem-resistant Acinetobacter baumannii isolated from different sources using multilocus sequence typing scheme. Infect Genet Evol 2021; 96:105132 [View Article] [PubMed]
     [Google Scholar]
  93. Shelenkov A, Petrova L, Zamyatin M, Mikhaylova Y, Akimkin V. Diversity of international high-risk clones of Acinetobacter baumannii revealed in a Russian Multidisciplinary Medical Center during 2017-2019. Antibiotics 2021; 10:1009 [View Article] [PubMed]
     [Google Scholar]
  94. Alcántar-Curiel MD, Rosales-Reyes R, Jarillo-Quijada MD, Gayosso-Vázquez C, Fernández-Vázquez JL et al. Carbapenem-resistant Acinetobacter baumannii in Three Tertiary Care Hospitals in Mexico: virulence profiles, innate immune response and clonal dissemination. Front Microbiol 2019; 10:2116 [View Article] [PubMed]
     [Google Scholar]
  95. Hamed SM, Hussein AFA, Al-Agamy MH, Radwan HH, Zafer MM. Genetic configuration of genomic resistance islands in Acinetobacter baumannii clinical isolates from Egypt. Front Microbiol 2022; 13:878912 [View Article] [PubMed]
     [Google Scholar]
  96. Xiao T, Guo Q, Zhou Y, Shen P, Wang Y et al. Comparative respiratory tract microbiome between carbapenem-resistant Acinetobacter baumannii colonization and ventilator associated pneumonia. Front Microbiol 2022; 13:782210 [View Article] [PubMed]
     [Google Scholar]
  97. Jouybari MA, Ahanjan M, Mirzaei B, Goli HR. Role of aminoglycoside-modifying enzymes and 16S rRNA methylase (ArmA) in resistance of Acinetobacter baumannii clinical isolates against aminoglycosides. Rev Soc Bras Med Trop 2021; 54:e05992020 [View Article] [PubMed]
     [Google Scholar]
  98. Mortazavi SM, Farshadzadeh Z, Janabadi S, Musavi M, Shahi F et al. Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran. New Microbes New Infect 2020; 38:100779 [View Article] [PubMed]
     [Google Scholar]
  99. Rashvand P, Peymani A, Mohammadi M, Karami AA, Samimi R et al. Molecular survey of aminoglycoside-resistant Acinetobacter baumannii isolated from tertiary hospitals in Qazvin, Iran. New Microbes New Infect 2021; 42:100883 [View Article] [PubMed]
     [Google Scholar]
  100. Ayoub Moubareck C, Hammoudi Halat D. Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics 2020; 9:119 [View Article] [PubMed]
     [Google Scholar]
  101. Blackwell GA, Holt KE, Bentley SD, Hsu LY, Hall RM. Variants of AbGRI3 carrying the armA gene in extensively antibiotic-resistant Acinetobacter baumannii from Singapore. J Antimicrob Chemother 2017; 72:1031–1039 [View Article] [PubMed]
     [Google Scholar]
  102. Hamed SM, Elkhatib WF, Brangsch H, Gesraha AS, Moustafa S et al. Acinetobacter baumannii global clone-specific resistomes explored in clinical isolates recovered from Egypt. Antibiotics 2023; 12:1149 [View Article] [PubMed]
     [Google Scholar]
  103. Wei C, Chen J, Anwar TM, Huang L, Yang W et al. Genomic determinants of pathogenicity and antimicrobial resistance of nosocomial Acinetobacter baumannii clinical isolates of hospitalized patients (2019-2021) from a Sentinel Hospital in Hangzhou, China. Infect Drug Resist 2023; 16:2939–2952 [View Article] [PubMed]
     [Google Scholar]
  104. Valcek A, Nesporova K, Whiteway C, De Pooter T, De Coster W et al. Genomic analysis of a strain collection containing multidrug-, extensively drug-, pandrug-, and carbapenem-resistant modern clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 2022; 66:e0089222 [View Article] [PubMed]
     [Google Scholar]
  105. Kuo SC, Huang WC, Huang TW, Wang HY, Lai JF et al. Molecular epidemiology of emerging blaoxa-23-like-and blaoxa-24-like-carrying Acinetobacter baumannii in Taiwan. Antimicrob Agents Chemother 2018; 62:e01215-17 [View Article]
     [Google Scholar]
  106. Jeamsripong S, Li X, Aly SS, Su Z, Pereira RV et al. Antibiotic resistance genes and associated phenotypes in Escherichia coli and Enterococcus from cattle at different production stages on a dairy farm in central California. Antibiotics 2021; 10:1042 [View Article] [PubMed]
     [Google Scholar]
  107. Beheshti M, Ardebili A, Beheshti F, Lari AR, Siyadatpanah A et al. Tetracycline resistance mediated by tet efflux pumps in clinical isolates of Acinetobacter baumannii. Rev Inst Med Trop Sao Paulo 2020; 62:e88 [View Article] [PubMed]
     [Google Scholar]
  108. Lashinsky JN, Henig O, Pogue JM, Kaye KS. Minocycline for the treatment of multidrug and extensively drug-resistant A. baumannii: a review. Infect Dis Ther 2017; 6:199–211 [View Article] [PubMed]
     [Google Scholar]
  109. Kakoullis L, Papachristodoulou E, Chra P, Panos G. Mechanisms of antibiotic resistance in important gram-positive and gram-negative pathogens and novel antibiotic solutions. Antibiotics 2021; 10:415 [View Article] [PubMed]
     [Google Scholar]
  110. Baleivanualala SC, Isaia L, Devi SV, Howden B, Gorrie CL et al. Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii ST2 in Oceania: a multicountry cohort study. Lancet Reg Health West Pac 2023; 40:100896 [View Article] [PubMed]
     [Google Scholar]
  111. Morgado SM, Fonseca ÉL, Freitas FS, Bighi NS, Oliveira PP et al. Outbreak of high-risk XDR CRAB of international clone 2 (IC2) in rio janeiro. Brazil J Glob Antimicrob Resist 2023; 34:91–98 [View Article]
     [Google Scholar]
  112. Mancilla-Rojano J, Flores V, Cevallos MA, Ochoa SA, Parra-Flores J et al. A bioinformatic approach to identify confirmed and probable CRISPR–cas systems in the acinetobacter calcoaceticus–Acinetobacter baumannii complex genomes. Front Microbiol 2024; 15:1335997 [View Article]
     [Google Scholar]
  113. Yu T, Huang J, Huang X, Hao J, Zhang P et al. Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii. Front Microbiol 2024; 15:1381749 [View Article] [PubMed]
     [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.001345
Loading
Whole-genome sequencing of Acinetobacter baumannii clinical isolates from a tertiary hospital in Terengganu, Malaysia (2011–2020), revealed the predominance of the Global Clone 2 lineage
M Gen 11, 001345 (2025); https://doi.org/10.1099/mgen.0.001345
/content/journal/mgen/10.1099/mgen.0.001345
/content/journal/mgen/10.1099/mgen.0.001345
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error